Submitted via IRC for SoyCow1984
Drug companies are sitting on generics—43% of recently approved aren't for sale
Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700—or 43 percent—are not for sale in the US, according to a new analysis by Kaiser Health News.
The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.
(Score: 3, Informative) by PartTimeZombie on Monday February 11 2019, @02:43AM (1 child)
I was thinking about countries with proper healthcare, not that ridiculous cash-grab you guys suffer with in the US.
(Score: -1, Troll) by Anonymous Coward on Monday February 11 2019, @03:02AM
Yes, you left what is "proper" up to the government. Next is the EU (or whatever your local super-gov is called), then the UN. Easier to control.
Each level up means you have less control even under the ideal democracy scenario.
Do you disagree with any of this?